ArticleBreast cancer research and treatment2023

Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer.

Shinsuke Sasada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.